Skip to main content

Table 1 Risk Ratio and Hazard Ratio for survival on the basis of ALT status

From: Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis

Parameter

N Cohorts

Risk Ratio (95% CI)

p Value

Heterogeneity (I2%); tau2

Egger Test (p value)

Survival

8

1.50 (1.15–1.96)

0.003

53%; 0.07

1.49 (0.17)

Parameter

N Cohorts

Hazard Ratio (95% CI)

p Value

Heterogeneity (I2); tau2

Egger Test (p value)

Survival

6

2.02 (1.22–3.38)

0.007

49.8%; 0.19

1.40 (0.57)